Life

Gen Re is pleased to present summary results of our 2021 Individual Life Accelerated Underwriting Survey.
 

It is important here to draw a distinction between what has historically been referred to as “accelerated underwriting” and the pandemic-fueled programs characterized as “alternative underwriting.”
 

Underwriters could reasonably ask whether a person with such a developmental learning disorder is at risk of worsening symptoms over time, leading to occupational disability, but can learning disorders really affect someone’s health status and lead to mental health issues?
 

In a time where tragedies have become more and more common, life insurance companies have adjusted to these new changes. Policies have generally remained the same, but there are some key differences worth discussing.
 

Insurers have known for a long time that the mortality rate of an insured population is much better than in the general population. This difference is critical for insurers, but there hasn’t been enough insurance data to fully understand mortality improvements, so we must rely on population mortality to guide our analysis.
 

Dr. Achim Regenauer, Chief Medical Officer, presents a high-level overview of targeted cancer therapy – a catch-all term for a spectrum of innovative new cancer therapies that are improving the outlook for patients and moving us closer to precision medicine – and its impact on Life & Health insurers.
 

Customers increasingly demand a seamless, non-intrusive, insurance purchasing experience. Multivariate technologies can empower life and health carriers to deliver. 
 

An increasingly common occurrence in an emergency room or even in a routine doctor office visit is the diagnosis of chest pain in a woman. 
 

Research collaboration between RGA and King’s College London shows potential of genetic predisposition in predicting common diseases